Skip to main content
SpringerLink
Log in

Genomic Applications in the Clinical Management of Infectious Diseases

  • Chapter
  • First Online:
Genomic Applications in Pathology

  • 2157 Accesses

Abstract

Next-generation sequencing (NGS) approaches to infectious disease diagnosis and monitoring demonstrate significant sensitivity and throughput advantages over conventional sequencing strategies. As NGS technologies become increasingly accessible and affordable, they are likely to become an important component of clinical microbiology testing. Here, we discuss recent studies that have used NGS platforms to address questions with relevance to diagnostic virology, bacteriology, and mycology. We focus on the advances made in the areas of viral drug resistance testing, detection of unknown disease-associated pathogens in clinical specimens, and investigation of microbial population diversity within the human host. We review different sequencing strategies, distinguishing between targeted amplicon sequencing versus whole-genome sequencing (WGS) approaches, and consider the technical and bioinformatics challenges that have emerged. Although NGS holds enormous promise for clinical microbiology, much remains to be accomplished, particularly in regard to standardizing technical protocols and bioinformatics tools, which would be prerequisites for the adoption of NGS methods in diagnostic testing.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 239.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Boyd SD. Diagnostic applications of high-throughput DNA sequencing. Annu Rev Pathol. 2012.

    Google Scholar 

  2. Loman NJ, Constantinidou C, Chan JZ, Halachev M, Sergeant M, Penn CW, Robinson ER, Pallen MJ. High-throughput bacterial genome sequencing: an embarrassment of choice, a world of opportunity. Nat Rev Microbiol. 2012;10:599–606.

    PubMed  CAS  Google Scholar 

  3. Anderson MW, Schrijver I. Next generation DNA sequencing and the future of genomic medicine. Genes. 2010;1:38–69.

    PubMed  CAS  PubMed Central  Google Scholar 

  4. Loman NJ, Misra RV, Dallman TJ, Constantinidou C, Gharbia SE, Wain J, Pallen MJ. Performance comparison of benchtop high-throughput sequencing platforms. Nat Biotechnol. 2012;30:434–9.

    PubMed  CAS  Google Scholar 

  5. Hoffmann C, Minkah N, Leipzig J, Wang G, Arens MQ, Tebas P, Bushman FD. DNA bar coding and pyrosequencing to identify rare HIV drug resistance mutations. Nucleic Acids Res. 2007;35:e91.

    PubMed  PubMed Central  Google Scholar 

  6. Hamady M, Walker JJ, Harris JK, Gold NJ, Knight R. Error-correcting barcoded primers for pyrosequencing hundreds of samples in multiplex. Nat Methods. 2008;5:235–7.

    PubMed  CAS  PubMed Central  Google Scholar 

  7. Vrancken B, Lequime S, Theys K, Lemey P. Covering all bases in HIV research: unveiling a hidden world of viral evolution. AIDS Rev. 2010;12:89–102.

    PubMed  Google Scholar 

  8. Radford AD, Chapman D, Dixon L, Chantrey J, Darby AC, Hall N. Application of next-generation sequencing technologies in virology. J Gen Virol. 2012;93:1853–68.

    PubMed  CAS  PubMed Central  Google Scholar 

  9. Weinstock GM. Genomic approaches to studying the human microbiota. Nature. 2012;489:250–6.

    PubMed  CAS  PubMed Central  Google Scholar 

  10. Greninger AL, Chen EC, Sittler T, Scheinerman A, Roubinian N, Yu G, Kim E, Pillai DR, Guyard C, Mazzulli T, et al. A metagenomic analysis of pandemic influenza A (2009 H1N1) infection in patients from North America. PLoS One. 2010;5:e13381.

    PubMed  PubMed Central  Google Scholar 

  11. Yozwiak NL, Skewes-Cox P, Stenglein MD, Balmaseda A, Harris E, DeRisi JL. Virus identification in unknown tropical febrile illness cases using deep sequencing. PLoS Negl Trop Dis. 2012;6:e1485.

    PubMed  PubMed Central  Google Scholar 

  12. Cortez KJ, Maldarelli F. Clinical management of HIV drug resistance. Viruses. 2011;3:347–78.

    PubMed  CAS  PubMed Central  Google Scholar 

  13. Johnson VA, Calvez V, Gunthard HF, Paredes R, Pillay D, Shafer R, Wensing AM, Richman DD. 2011 update of the drug resistance mutations in HIV-1. Top Antivir Med. 2011;19:156–64.

    PubMed  Google Scholar 

  14. Grant PM, Zolopa AR. The use of resistance testing in the management of HIV-1-infected patients. Curr Opin HIV AIDS. 2009;4:474–80.

    PubMed  Google Scholar 

  15. Dunn DT, Coughlin K, Cane PA. Genotypic resistance testing in routine clinical care. Curr Opin HIV AIDS. 2011;6:251–7.

    PubMed  Google Scholar 

  16. Vandamme AM, Camacho RJ, Ceccherini-Silberstein F, de Luca A, Palmisano L, Paraskevis D, Paredes R, Poljak M, Schmit JC, Soriano V, et al. European recommendations for the clinical use of HIV drug resistance testing: 2011 update. AIDS Rev. 2011;13:77–108.

    PubMed  Google Scholar 

  17. Tang MW, Liu TF, Shafer RW. The HIVdb system for HIV-1 genotypic resistance interpretation. Intervirology. 2012;55:98–101.

    PubMed  Google Scholar 

  18. Woods CK, Brumme CJ, Liu TF, Chui CK, Chu AL, Wynhoven B, Hall TA, Trevino C, Shafer RW, Harrigan PR. Automating HIV drug resistance genotyping with RECall, a freely accessible sequence analysis tool. J Clin Microbiol. 2012;50:1936–42.

    PubMed  CAS  PubMed Central  Google Scholar 

  19. Lengauer T, Sing T. Bioinformatics-assisted anti-HIV therapy. Nat Rev Microbiol. 2006;4:790–7.

    PubMed  CAS  Google Scholar 

  20. Zazzi M, Kaiser R, Sonnerborg A, Struck D, Altmann A, Prosperi M, Rosen-Zvi M, Petroczi A, Peres Y, Schulter E, et al. Prediction of response to antiretroviral therapy by human experts and by the EuResist data-driven expert system (the EVE study). HIV Med. 2011;12:211–8.

    PubMed  CAS  Google Scholar 

  21. Beerenwinkel N, Daumer M, Oette M, Korn K, Hoffmann D, Kaiser R, Lengauer T, Selbig J, Walter H. Geno2pheno: estimating phenotypic drug resistance from HIV-1 genotypes. Nucleic Acids Res. 2003;31:3850–5.

    PubMed  CAS  PubMed Central  Google Scholar 

  22. Johnson JA, Li JF, Wei X, Lipscomb J, Irlbeck D, Craig C, Smith A, Bennett DE, Monsour M, Sandstrom P, et al. Minority HIV-1 drug resistance mutations are present in antiretroviral treatment-naive populations and associate with reduced treatment efficacy. PLoS Med. 2008;5:e158.

    PubMed  PubMed Central  Google Scholar 

  23. Li JZ, Paredes R, Ribaudo HJ, Svarovskaia ES, Metzner KJ, Kozal MJ, Hullsiek KH, Balduin M, Jakobsen MR, Geretti AM, et al. Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis. JAMA. 2011;305:1327–35.

    PubMed  CAS  PubMed Central  Google Scholar 

  24. Metzner KJ, Giulieri SG, Knoepfel SA, Rauch P, Burgisser P, Yerly S, Gunthard HF, Cavassini M. Minority quasispecies of drug-resistant HIV-1 that lead to early therapy failure in treatment-naive and -adherent patients. Clin Infect Dis. 2009;48:239–47.

    PubMed  Google Scholar 

  25. Wang C, Mitsuya Y, Gharizadeh B, Ronaghi M, Shafer RW. Characterization of mutation spectra with ultra-deep pyrosequencing: application to HIV-1 drug resistance. Genome Res. 2007;17:1195–201.

    PubMed  CAS  PubMed Central  Google Scholar 

  26. Mitsuya Y, Varghese V, Wang C, Liu TF, Holmes SP, Jayakumar P, Gharizadeh B, Ronaghi M, Klein D, Fessel WJ, et al. Minority human immunodeficiency virus type 1 variants in antiretroviral-naive persons with reverse transcriptase codon 215 revertant mutations. J Virol. 2008;82:10747–55.

    PubMed  CAS  PubMed Central  Google Scholar 

  27. Fisher R, van Zyl GU, Travers SA, Kosakovsky Pond SL, Engelbrech S, Murrell B, Scheffler K, Smith D. Deep sequencing reveals minor protease resistance mutations in patients failing a protease inhibitor regimen. J Virol. 2012;86:6231–7.

    PubMed  CAS  PubMed Central  Google Scholar 

  28. Le T, Chiarella J, Simen BB, Hanczaruk B, Egholm M, Landry ML, Dieckhaus K, Rosen MI, Kozal MJ. Low-abundance HIV drug-resistant viral variants in treatment-experienced persons correlate with historical antiretroviral use. PLoS One. 2009;4:e6079.

    PubMed  PubMed Central  Google Scholar 

  29. Simen BB, Simons JF, Hullsiek KH, Novak RM, Macarthur RD, Baxter JD, Huang C, Lubeski C, Turenchalk GS, Braverman MS, et al. Low-abundance drug-resistant viral variants in chronically HIV-infected, antiretroviral treatment-naive patients significantly impact treatment outcomes. J Infect Dis. 2009;199:693–701.

    PubMed  Google Scholar 

  30. Varghese V, Shahriar R, Rhee SY, Liu T, Simen BB, Egholm M, Hanczaruk B, Blake LA, Gharizadeh B, Babrzadeh F, et al. Minority variants associated with transmitted and acquired HIV-1 nonnucleoside reverse transcriptase inhibitor resistance: implications for the use of second-generation nonnucleoside reverse transcriptase inhibitors. J Acquir Immune Defic Syndr. 2009;52:309–15.

    PubMed  CAS  PubMed Central  Google Scholar 

  31. Lataillade M, Chiarella J, Yang R, Schnittman S, Wirtz V, Uy J, Seekins D, Krystal M, Mancini M, McGrath D, et al. Prevalence and clinical significance of HIV drug resistance mutations by ultra-deep sequencing in antiretroviral-naive subjects in the CASTLE study. PLoS One. 2010;5:e10952.

    PubMed  PubMed Central  Google Scholar 

  32. Hedskog C, Mild M, Jernberg J, Sherwood E, Bratt G, Leitner T, Lundeberg J, Andersson B, Albert J. Dynamics of HIV-1 quasispecies during antiviral treatment dissected using ultra-deep pyrosequencing. PLoS One. 2010;5:e11345.

    PubMed  PubMed Central  Google Scholar 

  33. Mukherjee R, Jensen ST, Male F, Bittinger K, Hodinka RL, Miller MD, Bushman FD. Switching between raltegravir resistance pathways analyzed by deep sequencing. AIDS. 2011;25:1951–9.

    PubMed  CAS  PubMed Central  Google Scholar 

  34. Armenia D, Vandenbroucke I, Fabeni L, Van Marck H, Cento V, D’Arrigo R, Van Wesenbeeck L, Scopelliti F, Micheli V, Bruzzone B, et al. Study of genotypic and phenotypic HIV-1 dynamics of integrase mutations during raltegravir treatment: a refined analysis by ultra-deep 454 pyrosequencing. J Infect Dis. 2012;205:557–67.

    PubMed  CAS  PubMed Central  Google Scholar 

  35. Archer J, Braverman MS, Taillon BE, Desany B, James I, Harrigan PR, Lewis M, Robertson DL. Detection of low-frequency pretherapy chemokine (CXC motif) receptor 4 (CXCR4)-using HIV-1 with ultra-deep pyrosequencing. AIDS. 2009;23:1209–18.

    PubMed  CAS  PubMed Central  Google Scholar 

  36. Bunnik EM, Swenson LC, Edo-Matas D, Huang W, Dong W, Frantzell A, Petropoulos CJ, Coakley E, Schuitemaker H, Harrigan PR, et al. Detection of inferred CCR5- and CXCR4-using HIV-1 variants and evolutionary intermediates using ultra-deep pyrosequencing. PLoS Pathog. 2011;7:e1002106.

    PubMed  CAS  PubMed Central  Google Scholar 

  37. Tsibris AM, Korber B, Arnaout R, Russ C, Lo CC, Leitner T, Gaschen B, Theiler J, Paredes R, Su Z, et al. Quantitative deep sequencing reveals dynamic HIV-1 escape and large population shifts during CCR5 antagonist therapy in vivo. PLoS One. 2009;4:e5683.

    PubMed  PubMed Central  Google Scholar 

  38. Codoner FM, Pou C, Thielen A, Garcia F, Delgado R, Dalmau D, Alvarez-Tejado M, Ruiz L, Clotet B, Paredes R. Added value of deep sequencing relative to population sequencing in heavily pre-treated HIV-1-infected subjects. PLoS One. 2011;6:e19461.

    PubMed  CAS  PubMed Central  Google Scholar 

  39. Rothberg JM, Leamon JH. The development and impact of 454 sequencing. Nat Biotechnol. 2008;26:1117–24.

    PubMed  CAS  Google Scholar 

  40. Gorzer I, Guelly C, Trajanoski S, Puchhammer-Stockl E. The impact of PCR-generated recombination on diversity estimation of mixed viral populations by deep sequencing. J Virol Methods. 2010;169:248–52.

    PubMed  Google Scholar 

  41. Mild M, Hedskog C, Jernberg J, Albert J. Performance of ultra-deep pyrosequencing in analysis of HIV-1 pol gene variation. PLoS One. 2011;6:e22741.

    PubMed  CAS  PubMed Central  Google Scholar 

  42. Harismendy O, Ng PC, Strausberg RL, Wang X, Stockwell TB, Beeson KY, Schork NJ, Murray SS, Topol EJ, Levy S, et al. Evaluation of next generation sequencing platforms for population targeted sequencing studies. Genome Biol. 2009;10:R32.

    PubMed  PubMed Central  Google Scholar 

  43. Becker EA, Burns CM, Leon EJ, Rajabojan S, Friedman R, Friedrich TC, O’Connor SL, Hughes AL. Experimental analysis of sources of error in evolutionary studies based on Roche/454 pyrosequencing of viral genomes. Genome Biol Evol. 2012;4:457–65.

    PubMed  CAS  PubMed Central  Google Scholar 

  44. Skums P, Dimitrova Z, Campo DS, Vaughan G, Rossi L, Forbi JC, Yokosawa J, Zelikovsky A, Khudyakov Y. Efficient error correction for next-generation sequencing of viral amplicons. BMC Bioinformatics. 2012;13 Suppl 10:S6.

    PubMed  CAS  PubMed Central  Google Scholar 

  45. Dudley DM, Chin EN, Bimber BN, Sanabani SS, Tarosso LF, Costa PR, Sauer MM, Kallas EG, O’Connor DH. Low-cost ultra-wide genotyping using Roche/454 pyrosequencing for surveillance of HIV drug resistance. PLoS One. 2012;7:e36494.

    PubMed  CAS  PubMed Central  Google Scholar 

  46. Eriksson N, Pachter L, Mitsuya Y, Rhee SY, Wang C, Gharizadeh B, Ronaghi M, Shafer RW, Beerenwinkel N. Viral population estimation using pyrosequencing. PLoS Comput Biol. 2008;4:e1000074.

    PubMed  PubMed Central  Google Scholar 

  47. Zagordi O, Geyrhofer L, Roth V, Beerenwinkel N. Deep sequencing of a genetically heterogeneous sample: local haplotype reconstruction and read error correction. J Comput Biol. 2010;17:417–28.

    PubMed  CAS  Google Scholar 

  48. Jabara CB, Jones CD, Roach J, Anderson JA, Swanstrom R. Accurate sampling and deep sequencing of the HIV-1 protease gene using a Primer ID. Proc Natl Acad Sci U S A. 2011;108:20166–71.

    PubMed  CAS  PubMed Central  Google Scholar 

  49. Vandenbroucke I, Van Marck H, Mostmans W, Van Eygen V, Rondelez E, Thys K, Van Baelen K, Fransen K, Vaira D, Kabeya K, et al. HIV-1V3 envelope deep sequencing for clinical plasma specimens failing in phenotypic tropism assays. AIDS Res Ther. 2010;7:4.

    PubMed  PubMed Central  Google Scholar 

  50. Chevaliez S, Rodriguez C, Pawlotsky JM. New virologic tools for management of chronic hepatitis B and C. Gastroenterology. 2012;142:1303–1313 e1301

    Google Scholar 

  51. Fung J, Lai CL, Seto WK, Yuen MF. Nucleoside/nucleotide analogues in the treatment of chronic hepatitis B. J Antimicrob Chemother. 2011;66:2715–25.

    PubMed  CAS  Google Scholar 

  52. Pawlotsky JM. Treatment failure and resistance with direct-acting antiviral drugs against hepatitis C virus. Hepatology. 2011;53:1742–51.

    PubMed  CAS  Google Scholar 

  53. Yuen MF, Seto WK, Chow DH, Tsui K, Wong DK, Ngai VW, Wong BC, Fung J, Yuen JC, Lai CL. Long-term lamivudine therapy reduces the risk of long-term complications of chronic hepatitis B infection even in patients without advanced disease. Antivir Ther. 2007;12:1295–303.

    PubMed  CAS  Google Scholar 

  54. Tan Y, Ding K, Su J, Trinh X, Peng Z, Gong Y, Chen L, Cui Q, Lei N, Chen X, et al. The naturally occurring YMDD mutation among patients chronically infected HBV and untreated with lamivudine: a systematic review and meta-analysis. PLoS One. 2012;7:e32789.

    PubMed  CAS  PubMed Central  Google Scholar 

  55. Villet S, Pichoud C, Billioud G, Barraud L, Durantel S, Trepo C, Zoulim F. Impact of hepatitis B virus rtA181V/T mutants on hepatitis B treatment failure. J Hepatol. 2008;48:747–55.

    PubMed  CAS  Google Scholar 

  56. Hayer J, Jadeau F, Deleage G, Kay A, Zoulim F, Combet C. HBVdb: a knowledge database for hepatitis B virus. Nucleic Acids Res. 2012.

    Google Scholar 

  57. Yuen LK, Ayres A, Littlejohn M, Colledge D, Edgely A, Maskill WJ, Locarnini SA, Bartholomeusz A. SeqHepB: a sequence analysis program and relational database system for chronic hepatitis B. Antiviral Res. 2007;75:64–74.

    PubMed  CAS  Google Scholar 

  58. Ko SY, Oh HB, Park CW, Lee HC, Lee JE. Analysis of hepatitis B virus drug-resistant mutant haplotypes by ultra-deep pyrosequencing. Clin Microbiol Infect. 2012;18:E404–11.

    PubMed  CAS  Google Scholar 

  59. Margeridon-Thermet S, Shulman NS, Ahmed A, Shahriar R, Liu T, Wang C, Holmes SP, Babrzadeh F, Gharizadeh B, Hanczaruk B, et al. Ultra-deep pyrosequencing of hepatitis B virus quasispecies from nucleoside and nucleotide reverse-transcriptase inhibitor (NRTI)-treated patients and NRTI-naive patients. J Infect Dis. 2009;199:1275–85.

    PubMed  CAS  PubMed Central  Google Scholar 

  60. Margeridon-Thermet S, Svarovskaia ES, Babrzadeh F, Martin R, Liu TF, Pacold M, Reuman EC, Holmes SP, Borroto-Esoda K, Shafer RW. Low-level persistence of drug-resistance mutations in hepatitis B virus-infected subjects with a past history of Lamivudine treatment. Antimicrob Agents Chemother. 2012.

    Google Scholar 

  61. Rodriguez-Frias F, Tabernero D, Quer J, Esteban JI, Ortega I, Domingo E, Cubero M, Camos S, Ferrer-Costa C, Sanchez A, et al. Ultra-deep pyrosequencing detects conserved genomic sites and quantifies linkage of drug-resistant amino acid changes in the hepatitis B virus genome. PLoS One. 2012;7:e37874.

    PubMed  CAS  PubMed Central  Google Scholar 

  62. Solmone M, Vincenti D, Prosperi MC, Bruselles A, Ippolito G, Capobianchi MR. Use of massively parallel ultradeep pyrosequencing to characterize the genetic diversity of hepatitis B virus in drug-resistant and drug-naive patients and to detect minor variants in reverse transcriptase and hepatitis B S antigen. J Virol. 2009;83:1718–26.

    PubMed  CAS  PubMed Central  Google Scholar 

  63. Nasu A, Marusawa H, Ueda Y, Nishijima N, Takahashi K, Osaki Y, Yamashita Y, Inokuma T, Tamada T, Fujiwara T, et al. Genetic heterogeneity of hepatitis C virus in association with antiviral therapy determined by ultra-deep sequencing. PLoS One. 2011;6:e24907.

    PubMed  CAS  PubMed Central  Google Scholar 

  64. Verbinnen T, Van Marck H, Vandenbroucke I, Vijgen L, Claes M, Lin TI, Simmen K, Neyts J, Fanning G, Lenz O. Tracking the evolution of multiple in vitro hepatitis C virus replicon variants under protease inhibitor selection pressure by 454 deep sequencing. J Virol. 2010;84:11124–33.

    PubMed  CAS  PubMed Central  Google Scholar 

  65. Lenz O, de Bruijne J, Vijgen L, Verbinnen T, Weegink C, Van Marck H, Vandenbroucke I, Peeters M, Simmen K, Fanning G., et al. Efficacy of re-treatment with TMC435 as combination therapy in hepatitis c virus-infected patients following TMC435 monotherapy. Gastroenterology. 2012;143:1176–1178 e1176.

    Google Scholar 

  66. Drew WL. Cytomegalovirus resistance testing: pitfalls and problems for the clinician. Clin Infect Dis. 2010;50:733–6.

    PubMed  CAS  Google Scholar 

  67. Lurain NS, Chou S. Antiviral drug resistance of human cytomegalovirus. Clin Microbiol Rev. 2010;23:689–712.

    PubMed  CAS  PubMed Central  Google Scholar 

  68. Baroco AL, Oldfield EC. Gastrointestinal cytomegalovirus disease in the immunocompromised patient. Curr Gastroenterol Rep. 2008;10:409–16.

    PubMed  Google Scholar 

  69. Ljungman P, Reusser P, de la Camara R, Einsele H, Engelhard D, Ribaud P, Ward K. Management of CMV infections: recommendations from the infectious diseases working party of the EBMT. Bone Marrow Transplant. 2004;33:1075–81.

    PubMed  CAS  Google Scholar 

  70. Myhre HA, Haug Dorenberg D, Kristiansen KI, Rollag H, Leivestad T, Asberg A, Hartmann A. Incidence and outcomes of ganciclovir-resistant cytomegalovirus infections in 1244 kidney transplant recipients. Transplantation. 2011;92:217–23.

    PubMed  CAS  Google Scholar 

  71. Limaye AP, Corey L, Koelle DM, Davis CL, Boeckh M. Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants. Lancet. 2000;356:645–9.

    PubMed  CAS  Google Scholar 

  72. Li F, Kenyon KW, Kirby KA, Fishbein DP, Boeckh M, Limaye AP. Incidence and clinical features of ganciclovir-resistant cytomegalovirus disease in heart transplant recipients. Clin Infect Dis. 2007;45:439–47.

    PubMed  CAS  Google Scholar 

  73. Hantz S, Garnier-Geoffroy F, Mazeron MC, Garrigue I, Merville P, Mengelle C, Rostaing L, Saint Marcoux F, Essig M, Rerolle JP, et al. Drug-resistant cytomegalovirus in transplant recipients: a French cohort study. J Antimicrob Chemother. 2010;65:2628–40.

    PubMed  CAS  Google Scholar 

  74. Boivin G, Gilbert C, Gaudreau A, Greenfield I, Sudlow R, Roberts NA. Rate of emergence of cytomegalovirus (CMV) mutations in leukocytes of patients with acquired immunodeficiency syndrome who are receiving valganciclovir as induction and maintenance therapy for CMV retinitis. J Infect Dis. 2001;184:1598–602.

    PubMed  CAS  Google Scholar 

  75. Gilbert C, Handfield J, Toma E, Lalonde R, Bergeron MG, Boivin G. Emergence and prevalence of cytomegalovirus UL97 mutations associated with ganciclovir resistance in AIDS patients. AIDS. 1998;12:125–9.

    PubMed  CAS  Google Scholar 

  76. Jabs DA, Dunn JP, Enger C, Forman M, Bressler N, Charache P. Cytomegalovirus retinitis and viral resistance. Prevalence of resistance at diagnosis, 1994. Cytomegalovirus Retinitis and Viral Resistance Study Group. Arch Ophthalmol. 1996;114:809–14.

    PubMed  CAS  Google Scholar 

  77. Martin BK, Ricks MO, Forman MS, Jabs DA. Change over time in incidence of ganciclovir resistance in patients with cytomegalovirus retinitis. Clin Infect Dis. 2007;44:1001–8.

    PubMed  CAS  Google Scholar 

  78. Kotton CN, Kumar D, Caliendo AM, Asberg A, Chou S, Snydman DR, Allen U, Humar A. International consensus guidelines on the management of cytomegalovirus in solid organ transplantation. Transplantation. 2010;89:779–95.

    PubMed  Google Scholar 

  79. Chevillotte M, von Einem J, Meier BM, Lin FM, Kestler HA, Mertens T. A new tool linking human cytomegalovirus drug resistance mutations to resistance phenotypes. Antiviral Res. 2010;85:318–27.

    PubMed  CAS  Google Scholar 

  80. Wang D, Coscoy L, Zylberberg M, Avila PC, Boushey HA, Ganem D, DeRisi JL. Microarray-based detection and genotyping of viral pathogens. Proc Natl Acad Sci U S A. 2002;99:15687–92.

    PubMed  CAS  PubMed Central  Google Scholar 

  81. Barzon L, Lavezzo E, Militello V, Toppo S, Palu G. Applications of next-generation sequencing technologies to diagnostic virology. Int J Mol Sci. 2011;12:7861–84.

    PubMed  CAS  PubMed Central  Google Scholar 

  82. Rector A, Tachezy R, Van Ranst M. A sequence-independent strategy for detection and cloning of circular DNA virus genomes by using multiply primed rolling-circle amplification. J Virol. 2004;78:4993–8.

    PubMed  CAS  PubMed Central  Google Scholar 

  83. de Vries M, Deijs M, Canuti M, van Schaik BD, Faria NR, van de Garde MD, Jachimowski LC, Jebbink MF, Jakobs M, Luyf AC, et al. A sensitive assay for virus discovery in respiratory clinical samples. PLoS One. 2011;6:e16118.

    PubMed  PubMed Central  Google Scholar 

  84. Pyrc K, Jebbink MF, Berkhout B, van der Hoek L. Detection of new viruses by VIDISCA. Virus discovery based on cDNA-amplified fragment length polymorphism. Methods Mol Biol. 2008;454:73–89.

    PubMed  CAS  Google Scholar 

  85. Depledge DP, Palser AL, Watson SJ, Lai IY, Gray ER, Grant P, Kanda RK, Leproust E, Kellam P, Breuer J. Specific capture and whole-genome sequencing of viruses from clinical samples. PLoS One. 2011;6:e27805.

    PubMed  CAS  PubMed Central  Google Scholar 

  86. Duncavage EJ, Magrini V, Becker N, Armstrong JR, Demeter RT, Wylie T, Abel HJ, Pfeifer JD. Hybrid capture and next-generation sequencing identify viral integration sites from formalin-fixed, paraffin-embedded tissue. J Mol Diagn. 2011;13:325–33.

    PubMed  CAS  PubMed Central  Google Scholar 

  87. Bhaduri A, Qu K, Lee CS, Ungewickell A, Khavari PA. Rapid identification of non-human sequences in high-throughput sequencing datasets. Bioinformatics. 2012;28:1174–5.

    PubMed  CAS  PubMed Central  Google Scholar 

  88. Kostic AD, Ojesina AI, Pedamallu CS, Jung J, Verhaak RG, Getz G, Meyerson M. PathSeq: software to identify or discover microbes by deep sequencing of human tissue. Nat Biotechnol. 2011;29:393–6.

    PubMed  CAS  PubMed Central  Google Scholar 

  89. Berthet N, Reinhardt AK, Leclercq I, van Ooyen S, Batejat C, Dickinson P, Stamboliyska R, Old IG, Kong KA, Dacheux L, et al. Phi29 polymerase based random amplification of viral RNA as an alternative to random RT-PCR. BMC Mol Biol. 2008;9:77.

    PubMed  PubMed Central  Google Scholar 

  90. Cheval J, Sauvage V, Frangeul L, Dacheux L, Guigon G, Dumey N, Pariente K, Rousseaux C, Dorange F, Berthet N, et al. Evaluation of high-throughput sequencing for identifying known and unknown viruses in biological samples. J Clin Microbiol. 2011;49:3268–75.

    PubMed  CAS  PubMed Central  Google Scholar 

  91. Miller JR, Koren S, Sutton G. Assembly algorithms for next-generation sequencing data. Genomics. 2010;95:315–27.

    PubMed  CAS  PubMed Central  Google Scholar 

  92. Palacios G, Druce J, Du L, Tran T, Birch C, Briese T, Conlan S, Quan PL, Hui J, Marshall J, et al. A new arenavirus in a cluster of fatal transplant-associated diseases. N Engl J Med. 2008;358:991–8.

    PubMed  CAS  Google Scholar 

  93. Yozwiak NL, Skewes-Cox P, Gordon A, Saborio S, Kuan G, Balmaseda A, Ganem D, Harris E, DeRisi JL. Human enterovirus 109: a novel interspecies recombinant enterovirus isolated from a case of acute pediatric respiratory illness in Nicaragua. J Virol. 2010;84:9047–58.

    PubMed  CAS  PubMed Central  Google Scholar 

  94. Briese T, Paweska JT, McMullan LK, Hutchison SK, Street C, Palacios G, Khristova ML, Weyer J, Swanepoel R, Egholm M, et al. Genetic detection and characterization of Lujo virus, a new hemorrhagic fever-associated arenavirus from Southern Africa. PLoS Pathog. 2009;5:e1000455.

    PubMed  PubMed Central  Google Scholar 

  95. Hoper D, Hoffmann B, Beer M. A comprehensive deep sequencing strategy for full-length genomes of influenza A. PLoS One. 2011;6:e19075.

    PubMed  PubMed Central  Google Scholar 

  96. Yongfeng H, Fan Y, Jie D, Jian Y, Ting Z, Lilian S, Jin Q. Direct pathogen detection from swab samples using a new high-throughput sequencing technology. Clin Microbiol Infect. 2011;17:241–4.

    PubMed  CAS  Google Scholar 

  97. Feng H, Shuda M, Chang Y, Moore PS. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science. 2008;319:1096–100.

    PubMed  CAS  PubMed Central  Google Scholar 

  98. McMullan LK, Folk SM, Kelly AJ, MacNeil A, Goldsmith CS, Metcalfe MG, Batten BC, Albarino CG, Zaki SR, Rollin PE, et al. A new phlebovirus associated with severe febrile illness in Missouri. N Engl J Med. 2012;367:834–41.

    PubMed  CAS  Google Scholar 

  99. Bishop-Lilly KA, Turell MJ, Willner KM, Butani A, Nolan NM, Lentz SM, Akmal A, Mateczun A, Brahmbhatt TN, Sozhamannan S, et al. Arbovirus detection in insect vectors by rapid, high-throughput pyrosequencing. PLoS Negl Trop Dis. 2010;4:e878.

    PubMed  PubMed Central  Google Scholar 

  100. Falkow S. Molecular Koch’s postulates applied to bacterial pathogenicity–a personal recollection 15 years later. Nat Rev Microbiol. 2004;2:67–72.

    PubMed  CAS  Google Scholar 

  101. Fredericks DN, Relman DA. Sequence-based identification of microbial pathogens: a reconsideration of Koch’s postulates. Clin Microbiol Rev. 1996;9:18–33.

    PubMed  CAS  PubMed Central  Google Scholar 

  102. Mokili JL, Rohwer F, Dutilh BE. Metagenomics and future perspectives in virus discovery. Curr Opin Virol. 2012;2:63–77.

    PubMed  CAS  Google Scholar 

  103. Sanjuan R, Nebot MR, Chirico N, Mansky LM, Belshaw R. Viral mutation rates. J Virol. 2010;84:9733–48.

    PubMed  CAS  PubMed Central  Google Scholar 

  104. Lauring AS, Andino R. Quasispecies theory and the behavior of RNA viruses. PLoS Pathog. 2010;6:e1001005.

    PubMed  PubMed Central  Google Scholar 

  105. Renzette N, Bhattacharjee B, Jensen JD, Gibson L, Kowalik TF. Extensive genome-wide variability of human cytomegalovirus in congenitally infected infants. PLoS Pathog. 2011;7:e1001344.

    PubMed  CAS  PubMed Central  Google Scholar 

  106. Escobar-Gutierrez A, Vazquez-Pichardo M, Cruz-Rivera M, Rivera-Osorio P, Carpio-Pedroza JC, Ruiz-Pacheco JA, Ruiz-Tovar K, Vaughan G. Identification of hepatitis C virus transmission using a next-generation sequencing approach. J Clin Microbiol. 2012;50:1461–3.

    PubMed  CAS  PubMed Central  Google Scholar 

  107. Redd AD, Mullis CE, Serwadda D, Kong X, Martens C, Ricklefs SM, Tobian AA, Xiao C, Grabowski MK, Nalugoda F, et al. The rates of HIV superinfection and primary HIV incidence in a general population in Rakai, Uganda. J Infect Dis. 2012;206:267–74.

    PubMed  PubMed Central  Google Scholar 

  108. Buzon MJ, Codoner FM, Frost SD, Pou C, Puertas MC, Massanella M, Dalmau J, Llibre JM, Stevenson M, Blanco J, et al. Deep molecular characterization of HIV-1 dynamics under suppressive HAART. PLoS Pathog. 2011;7:e1002314.

    PubMed  CAS  PubMed Central  Google Scholar 

  109. Campbell MS, Mullins JI, Hughes JP, Celum C, Wong KG, Raugi DN, Sorensen S, Stoddard JN, Zhao H, Deng W, et al. Viral linkage in HIV-1 seroconverters and their partners in an HIV-1 prevention clinical trial. PLoS One. 2011;6:e16986.

    PubMed  CAS  PubMed Central  Google Scholar 

  110. Eshleman SH, Hudelson SE, Redd AD, Wang L, Debes R, Chen YQ, Martens CA, Ricklefs SM, Selig EJ, Porcella SF, et al. Analysis of genetic linkage of HIV from couples enrolled in the HIV Prevention Trials Network 052 trial. J Infect Dis. 2011;204:1918–26.

    PubMed  CAS  PubMed Central  Google Scholar 

  111. Ghedin E, Laplante J, DePasse J, Wentworth DE, Santos RP, Lepow ML, Porter J, Stellrecht K, Lin X, Operario D, et al. Deep sequencing reveals mixed infection with 2009 pandemic influenza A (H1N1) virus strains and the emergence of oseltamivir resistance. J Infect Dis. 2011;203:168–74.

    PubMed  CAS  PubMed Central  Google Scholar 

  112. Holmes EC, Ghedin E, Miller N, Taylor J, Bao Y, St George K, Grenfell BT, Salzberg SL, Fraser CM, Lipman DJ, et al. Whole-genome analysis of human influenza A virus reveals multiple persistent lineages and reassortment among recent H3N2 viruses. PLoS Biol. 2005;3:e300.

    PubMed  PubMed Central  Google Scholar 

  113. Roedig JV, Rapp E, Hoper D, Genzel Y, Reichl U. Impact of host cell line adaptation on quasispecies composition and glycosylation of influenza A virus hemagglutinin. PLoS One. 2011;6:e27989.

    PubMed  CAS  PubMed Central  Google Scholar 

  114. Parameswaran P, Charlebois P, Tellez Y, Nunez A, Ryan EM, Malboeuf CM, Levin JZ, Lennon NJ, Balmaseda A, Harris E, et al. Genome-wide patterns of intrahuman dengue virus diversity reveal associations with viral phylogenetic clade and interhost diversity. J Virol. 2012;86:8546–58.

    PubMed  CAS  PubMed Central  Google Scholar 

  115. Tapparel C, Cordey S, Junier T, Farinelli L, Van Belle S, Soccal PM, Aubert JD, Zdobnov E, Kaiser L. Rhinovirus genome variation during chronic upper and lower respiratory tract infections. PLoS One. 2011;6:e21163.

    PubMed  CAS  PubMed Central  Google Scholar 

  116. Gorzer I, Guelly C, Trajanoski S, Puchhammer-Stockl E. Deep sequencing reveals highly complex dynamics of human cytomegalovirus genotypes in transplant patients over time. J Virol. 2010;84:7195–203.

    PubMed  PubMed Central  Google Scholar 

  117. Astrovskaya I, Tork B, Mangul S, Westbrooks K, Mandoiu I, Balfe P, Zelikovsky A. Inferring viral quasispecies spectra from 454 pyrosequencing reads. BMC Bioinformatics. 2011;12 Suppl 6:S1.

    PubMed  PubMed Central  Google Scholar 

  118. Zagordi O, Bhattacharya A, Eriksson N, Beerenwinkel N. ShoRAH: estimating the genetic diversity of a mixed sample from next-generation sequencing data. BMC Bioinformatics. 2011;12:119.

    PubMed  PubMed Central  Google Scholar 

  119. Prosperi MC, Salemi M. QuRe: software for viral quasispecies reconstruction from next-generation sequencing data. Bioinformatics. 2012;28:132–3.

    PubMed  CAS  PubMed Central  Google Scholar 

  120. McHardy AC, Adams B. The role of genomics in tracking the evolution of influenza A virus. PLoS Pathog. 2009;5:e1000566.

    PubMed  PubMed Central  Google Scholar 

  121. Wang R, Taubenberger JK. Methods for molecular surveillance of influenza. Expert Rev Anti Infect Ther. 2010;8:517–27.

    PubMed  CAS  PubMed Central  Google Scholar 

  122. Ghedin E, Sengamalay NA, Shumway M, Zaborsky J, Feldblyum T, Subbu V, Spiro DJ, Sitz J, Koo H, Bolotov P, et al. Large-scale sequencing of human influenza reveals the dynamic nature of viral genome evolution. Nature. 2005;437:1162–6.

    PubMed  CAS  Google Scholar 

  123. Rambaut A, Pybus OG, Nelson MI, Viboud C, Taubenberger JK, Holmes EC. The genomic and epidemiological dynamics of human influenza A virus. Nature. 2008;453:615–9.

    PubMed  CAS  PubMed Central  Google Scholar 

  124. Jackson SE, Mason GM, Wills MR. Human cytomegalovirus immunity and immune evasion. Virus Res. 2011;157:151–60.

    PubMed  CAS  Google Scholar 

  125. Lisboa LF, Tong Y, Kumar D, Pang XL, Asberg A, Hartmann A, Rollag H, Jardine AG, Pescovitz MD, Humar A. Analysis and clinical correlation of genetic variation in cytomegalovirus. Transpl Infect Dis. 2012;14:132–40.

    PubMed  CAS  Google Scholar 

  126. Manuel O, Asberg A, Pang X, Rollag H, Emery VC, Preiksaitis JK, Kumar D, Pescovitz MD, Bignamini AA, Hartmann A, et al. Impact of genetic polymorphisms in cytomegalovirus glycoprotein B on outcomes in solid-organ transplant recipients with cytomegalovirus disease. Clin Infect Dis. 2009;49:1160–6.

    PubMed  CAS  Google Scholar 

  127. Didelot X, Bowden R, Wilson DJ, Peto TE, Crook DW. Transforming clinical microbiology with bacterial genome sequencing. Nat Rev Genet. 2012;13:601–12.

    PubMed  CAS  Google Scholar 

  128. Peterson J, Garges S, Giovanni M, McInnes P, Wang L, Schloss JA, Bonazzi V, McEwen JE, Wetterstrand KA, Deal C, et al. The NIH Human Microbiome Project. Genome Res. 2009;19:2317–23.

    PubMed  PubMed Central  Google Scholar 

  129. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010;464:59–65.

    PubMed  CAS  PubMed Central  Google Scholar 

  130. A framework for human microbiome research. Nature. 2012;486:215–21.

    Google Scholar 

  131. Srinivasan S, Hoffman NG, Morgan MT, Matsen FA, Fiedler TL, Hall RW, Ross FJ, McCoy CO, Bumgarner R, Marrazzo JM, et al. Bacterial communities in women with bacterial vaginosis: high resolution phylogenetic analyses reveal relationships of microbiota to clinical criteria. PLoS One. 2012;7:e37818.

    PubMed  CAS  PubMed Central  Google Scholar 

  132. VanDevanter DR, LiPuma JJ. Microbial diversity in the cystic fibrosis airways: where is thy sting? Future Microbiol. 2012;7:801–3.

    PubMed  CAS  Google Scholar 

  133. Zhao J, Schloss PD, Kalikin LM, Carmody LA, Foster BK, Petrosino JF, Cavalcoli JD, VanDevanter DR, Murray S, Li JZ, et al. Decade-long bacterial community dynamics in cystic fibrosis airways. Proc Natl Acad Sci U S A. 2012;109:5809–14.

    PubMed  CAS  PubMed Central  Google Scholar 

  134. Shahinas D, Silverman M, Sittler T, Chiu C, Kim P, Allen-Vercoe E, Weese S, Wong A, Low DE, Pillai DR. Toward an understanding of changes in diversity associated with fecal microbiome transplantation based on 16S rRNA gene deep sequencing. mBio. 2012;3.

    Google Scholar 

  135. Dethlefsen L, Huse S, Sogin ML, Relman DA. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol. 2008;6:e280.

    PubMed  PubMed Central  Google Scholar 

  136. Klindworth A, Pruesse E, Schweer T, Peplies J, Quast C, Horn M, Glockner FO. Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies. Nucleic Acids Res. 2012.

    Google Scholar 

  137. Kuczynski J, Lauber CL, Walters WA, Parfrey LW, Clemente JC, Gevers D, Knight R. Experimental and analytical tools for studying the human microbiome. Nat Rev Genet. 2012;13:47–58.

    CAS  Google Scholar 

  138. Jolley KA, Bliss CM, Bennett JS, Bratcher HB, Brehony C, Colles FM, Wimalarathna H, Harrison OB, Sheppard SK, Cody AJ, et al. Ribosomal multilocus sequence typing: universal characterization of bacteria from domain to strain. Microbiology. 2012;158:1005–15.

    PubMed  CAS  PubMed Central  Google Scholar 

  139. Pruesse E, Quast C, Knittel K, Fuchs BM, Ludwig W, Peplies J, Glockner FO. SILVA: a comprehensive online resource for quality checked and aligned ribosomal RNA sequence data compatible with ARB. Nucleic Acids Res. 2007;35:7188–96.

    PubMed  CAS  PubMed Central  Google Scholar 

  140. Quast C, Pruesse E, Yilmaz P, Gerken J, Schweer T, Yarza P, Peplies J, Glockner FO. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 2012.

    Google Scholar 

  141. McDonald D, Price MN, Goodrich J, Nawrocki EP, DeSantis TZ, Probst A, Andersen GL, Knight R, Hugenholtz P. An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea. ISME J. 2012;6:610–8.

    PubMed  CAS  PubMed Central  Google Scholar 

  142. Schloss PD, Gevers D, Westcott SL. Reducing the effects of PCR amplification and sequencing artifacts on 16S rRNA-based studies. PLoS One. 2011;6:e27310.

    PubMed  CAS  PubMed Central  Google Scholar 

  143. Edgar RC, Haas BJ, Clemente JC, Quince C, Knight R. UCHIME improves sensitivity and speed of chimera detection. Bioinformatics. 2011;27:2194–200.

    PubMed  CAS  PubMed Central  Google Scholar 

  144. Schloss PD, Westcott SL, Ryabin T, Hall JR, Hartmann M, Hollister EB, Lesniewski RA, Oakley BB, Parks DH, Robinson CJ, et al. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol. 2009;75:7537–41.

    PubMed  CAS  PubMed Central  Google Scholar 

  145. Haas BJ, Gevers D, Earl AM, Feldgarden M, Ward DV, Giannoukos G, Ciulla D, Tabbaa D, Highlander SK, Sodergren E, et al. Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons. Genome Res. 2011;21:494–504.

    PubMed  CAS  PubMed Central  Google Scholar 

  146. Reeder J, Knight R. Rapidly denoising pyrosequencing amplicon reads by exploiting rank-abundance distributions. Nat Methods. 2010;7:668–9.

    PubMed  CAS  PubMed Central  Google Scholar 

  147. Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Pena AG, Goodrich JK, Gordon JI, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods. 2010;7:335–6.

    PubMed  CAS  PubMed Central  Google Scholar 

  148. Kuroda M, Sekizuka T, Shinya F, Takeuchi F, Kanno T, Sata T, Asano S. Detection of a possible bioterrorism agent, Francisella sp., in a clinical specimen by use of next-generation direct DNA sequencing. J Clin Microbiol. 2012;50:1810–2.

    PubMed  CAS  PubMed Central  Google Scholar 

  149. Mellmann A, Harmsen D, Cummings CA, Zentz EB, Leopold SR, Rico A, Prior K, Szczepanowski R, Ji Y, Zhang W, et al. Prospective genomic characterization of the German enterohemorrhagic Escherichia coli O104:H4 outbreak by rapid next generation sequencing technology. PLoS One. 2011;6:e22751.

    PubMed  CAS  PubMed Central  Google Scholar 

  150. Vogel U, Szczepanowski R, Claus H, Junemann S, Prior K, Harmsen D. Ion torrent personal genome machine sequencing for genomic typing of Neisseria meningitidis for rapid determination of multiple layers of typing information. J Clin Microbiol. 2012;50:1889–94.

    PubMed  CAS  PubMed Central  Google Scholar 

  151. Hofreuter D, Tsai J, Watson RO, Novik V, Altman B, Benitez M, Clark C, Perbost C, Jarvie T, Du L, et al. Unique features of a highly pathogenic Campylobacter jejuni strain. Infect Immun. 2006;74:4694–707.

    PubMed  CAS  PubMed Central  Google Scholar 

  152. Smith MG, Gianoulis TA, Pukatzki S, Mekalanos JJ, Ornston LN, Gerstein M, Snyder M. New insights into Acinetobacter baumannii pathogenesis revealed by high-density pyrosequencing and transposon mutagenesis. Genes Dev. 2007;21:601–14.

    PubMed  CAS  PubMed Central  Google Scholar 

  153. Andries K, Verhasselt P, Guillemont J, Gohlmann HW, Neefs JM, Winkler H, Van Gestel J, Timmerman P, Zhu M, Lee E, et al. A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis. Science. 2005;307:223–7.

    PubMed  CAS  Google Scholar 

  154. Perez Chaparro PJ, McCulloch JA, Cerdeira LT, Al-Dilaimi A, Canto de Sa LL, de Oliveira R, Tauch A, de Carvalho Azevedo VA, Cruz Schneider MP, da Silva AL. Whole genome sequencing of environmental Vibrio cholerae O1 from 10 nanograms of DNA using short reads. J Microbiol Methods. 2011;87:208–12.

    PubMed  CAS  Google Scholar 

  155. Chin CS, Sorenson J, Harris JB, Robins WP, Charles RC, Jean-Charles RR, Bullard J, Webster DR, Kasarskis A, Peluso P, et al. The origin of the Haitian cholera outbreak strain. N Engl J Med. 2011;364:33–42.

    PubMed  CAS  PubMed Central  Google Scholar 

  156. McAdam PR, Holmes A, Templeton KE, Fitzgerald JR. Adaptive evolution of Staphylococcus aureus during chronic endobronchial infection of a cystic fibrosis patient. PLoS One. 2011;6:e24301.

    PubMed  CAS  PubMed Central  Google Scholar 

  157. Koser CU, Holden MT, Ellington MJ, Cartwright EJ, Brown NM, Ogilvy-Stuart AL, Hsu LY, Chewapreecha C, Croucher NJ, Harris SR, et al. Rapid whole-genome sequencing for investigation of a neonatal MRSA outbreak. N Engl J Med. 2012;366:2267–75.

    PubMed  CAS  PubMed Central  Google Scholar 

  158. Jenkins SG, Schuetz AN. Current concepts in laboratory testing to guide antimicrobial therapy. Mayo Clin Proc. 2012;87:290–308.

    PubMed  CAS  PubMed Central  Google Scholar 

  159. Heysell SK, Houpt ER. The future of molecular diagnostics for drug-resistant tuberculosis. Expert Rev Mol Diagn. 2012;12:395–405.

    PubMed  CAS  Google Scholar 

  160. Chen PE, Willner KM, Butani A, Dorsey S, George M, Stewart A, Lentz SM, Cook CE, Akmal A, Price LB, et al. Rapid identification of genetic modifications in Bacillus anthracis using whole genome draft sequences generated by 454 pyrosequencing. PLoS One. 2010;5:e12397.

    PubMed  PubMed Central  Google Scholar 

  161. Structure, function and diversity of the healthy human microbiome. Nature. 2012;486:207–14.

    Google Scholar 

  162. Williamson SJ, Yooseph S. From bacterial to microbial ecosystems (metagenomics). Methods Mol Biol. 2012;804:35–55.

    PubMed  CAS  Google Scholar 

  163. Blair JE, Coakley B, Santelli AC, Hentz JG, Wengenack NL. Serologic testing for symptomatic coccidioidomycosis in immunocompetent and immunosuppressed hosts. Mycopathologia. 2006;162:317–24.

    PubMed  PubMed Central  Google Scholar 

  164. Hage CA, Ribes JA, Wengenack NL, Baddour LM, Assi M, McKinsey DS, Hammoud K, Alapat D, Babady NE, Parker M, et al. A multicenter evaluation of tests for diagnosis of histoplasmosis. Clin Infect Dis. 2011;53:448–54.

    PubMed  Google Scholar 

  165. Pagano L, Caira M, Offidani M, Martino B, Candoni A, Valentini CG, Specchia G, Nosari A, Tosti ME, Leone G, et al. Adherence to international guidelines for the treatment of invasive aspergillosis in acute myeloid leukaemia: feasibility and utility (SEIFEM-2008B study). J Antimicrob Chemother. 2010;65:2013–8.

    PubMed  CAS  Google Scholar 

  166. Balajee SA, Sigler L, Brandt ME. DNA and the classical way: identification of medically important molds in the 21st century. Med Mycol. 2007;45:475–90.

    PubMed  CAS  Google Scholar 

  167. Ciardo DE, Schar G, Bottger EC, Altwegg M, Bosshard PP. Internal transcribed spacer sequencing versus biochemical profiling for identification of medically important yeasts. J Clin Microbiol. 2006;44:77–84.

    PubMed  CAS  PubMed Central  Google Scholar 

  168. Ciardo DE, Lucke K, Imhof A, Bloemberg GV, Bottger EC. Systematic internal transcribed spacer sequence analysis for identification of clinical mold isolates in diagnostic mycology: a 5-year study. J Clin Microbiol. 2010;48:2809–13.

    PubMed  CAS  PubMed Central  Google Scholar 

  169. Pounder JI, Simmon KE, Barton CA, Hohmann SL, Brandt ME, Petti CA. Discovering potential pathogens among fungi identified as nonsporulating molds. J Clin Microbiol. 2007;45:568–71.

    PubMed  CAS  PubMed Central  Google Scholar 

  170. Schoch CL, Seifert KA, Huhndorf S, Robert V, Spouge JL, Levesque CA, Chen W. Nuclear ribosomal internal transcribed spacer (ITS) region as a universal DNA barcode marker for Fungi. Proc Natl Acad Sci U S A. 2012;109:6241–6.

    PubMed  CAS  PubMed Central  Google Scholar 

  171. Munoz-Cadavid C, Rudd S, Zaki SR, Patel M, Moser SA, Brandt ME, Gomez BL. Improving molecular detection of fungal DNA in formalin-fixed paraffin-embedded tissues: comparison of five tissue DNA extraction methods using panfungal PCR. J Clin Microbiol. 2010;48:2147–53.

    PubMed  CAS  PubMed Central  Google Scholar 

  172. Lau A, Chen S, Sorrell T, Carter D, Malik R, Martin P, Halliday C. Development and clinical application of a panfungal PCR assay to detect and identify fungal DNA in tissue specimens. J Clin Microbiol. 2007;45:380–5.

    PubMed  CAS  PubMed Central  Google Scholar 

  173. Romanelli AM, Sutton DA, Thompson EH, Rinaldi MG, Wickes BL. Sequence-based identification of filamentous basidiomycetous fungi from clinical specimens: a cautionary note. J Clin Microbiol. 2010;48:741–52.

    PubMed  CAS  PubMed Central  Google Scholar 

  174. Bidartondo MI. Preserving accuracy in GenBank. Science. 2008;319:1616.

    PubMed  CAS  Google Scholar 

  175. Engelthaler DM, Chiller T, Schupp JA, Colvin J, Beckstrom-Sternberg SM, Driebe EM, Moses T, Tembe W, Sinari S, Beckstrom-Sternberg JS, et al. Next-generation sequencing of Coccidioides immitis isolated during cluster investigation. Emerg Infect Dis. 2011;17:227–32.

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA

    Martina I. Lefterova, Niaz Banaei & Benjamin A. Pinsky

  2. Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA

    Niaz Banaei & Benjamin A. Pinsky

  3. Clinical Microbiology and Virology Laboratories, Stanford University School of Medicine, Stanford, CA, USA

    Niaz Banaei & Benjamin A. Pinsky

Authors
  1. Martina I. Lefterova
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Niaz Banaei
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Benjamin A. Pinsky
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Departments of Pathology, Oncology and Urology, Johns Hopkins University, Baltimore, Maryland, USA

    George Jabboure Netto

  2. Department of Pathology, Stanford University School of Medicine, Stanford, California, USA

    Iris Schrijver

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Lefterova, M.I., Banaei, N., Pinsky, B.A. (2015). Genomic Applications in the Clinical Management of Infectious Diseases. In: Netto, G., Schrijver, I. (eds) Genomic Applications in Pathology. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-0727-4_33

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-0727-4_33

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-0726-7

  • Online ISBN: 978-1-4939-0727-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation